Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapies
The epidermal growth factor receptor (EGFR) is overexpressed in many cancers including lung, breast, head and neck and brain. Furthermore, mutations of this receptor have been shown to play crucial roles in response to EGFR-targeted therapies in non small cell lung carcinoma (NSCLC) patients. Imagin...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.634067 |